ClarIDHy: A Phase 3, multicenter, randomized, double-blind of orally administere
- This topic has 0 replies, 1 voice, and was last updated 4 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
ClarIDHy: A Phase 3, multicenter, randomized, double-blind of orally administered AG-120 for patients with advanced cholangiocarcinoma and an IDH1 gene mutation.
https://clinicaltrials.gov/ct2/show/NCT02989857
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.